LAMEA Human Insulin Market Size, Share & Trends Analysis Report By Indication, By Product Type (Pens, Syringes, and Others), By Type of Insulin, By Distribution Channel, By Country and Growth Forecast, 2024

List of Tables

The Latin America, Middle East and Africa Human Insulin Market would witness market growth of 5.5% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Human Insulin Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $451.8 million by 2031. The Argentina market is showcasing a CAGR of 6.4% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 4.8% during (2024 - 2031).

Technological advancements in biotechnology have significantly transformed the human insulin market, developing more effective and safer insulin analogs. These innovations have improved patient outcomes and driven market expansion by addressing some of the key limitations of traditional insulin therapies. Insulin analogs are modified insulin forms that mimic the body's natural insulin release patterns. Unlike regular the insulin, which has a standard action profile, insulin analogs can be engineered to have different onset times, peak activity periods, and durations of action. This enables the management of blood glucose levels to be more precise and adaptable.

Advances in genetic engineering and protein modification technologies have driven the development of these analogs. Scientists have developed molecules with enhanced pharmacokinetic properties by modifying the amino acid sequence of insulin, thereby improving their absorption, distribution, metabolism, and excretion profiles. These modifications have led to insulin analogs that are more effective in controlling blood glucose levels and offer a lower risk of adverse effects, such as hypoglycemia, a common and potentially dangerous side effect of insulin therapy.

The LAMEA region is witnessing significant growth in this insulin market, driven by improving healthcare access and rising diabetes prevalence. Diabetes has been on the rise at an alarming rate in Latin America, particularly in countries such as Brazil. As per the data provided in 2022 by the Pan American Health Organization, more than 30 million individuals in Brazil were 60 years of age or elderly, accounting for 13 percent of the country's total population. By 2030, this age group will comprise 24 percent of the Brazilian population or approximately 50 million individuals. This increase in the aging population has resulted in an increased number of diabetes cases, which has prompted a greater demand for insulin products. Through its Unified Health System (SUS), the Brazilian government has made concerted efforts to enhance healthcare infrastructure and expand access to essential medications. In addition, international aid programs and partnerships with organizations such as the World Health Organization (WHO) are facilitating the expansion of insulin availability to those in need and bridging the gaps in healthcare delivery. Therefore, the high prevalence of diabetes and risk factors across the region will support the regional market's growth.

Based on Indication, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes. Based on Product Type, the market is segmented into Pens, Syringes, and Others. Based on Type of Insulin, the market is segmented into Rapid-acting insulin, Short-acting insulin, Intermediate-acting insulin, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

MannKind Corporation
Lupin Limited
Sanofi S.A.
Novo Nordisk A/S
Eli Lilly And Company
Medtronic PLC
Biocon Limited
Tonghua Dongbao Pharmaceutical Co., Ltd.
Pfizer, Inc.

LAMEA Human Insulin Market Report Segmentation

By Indication

Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes

By Product Type

Pens
Syringes
Others

By Type of Insulin

Rapid-acting insulin
Short-acting insulin
Intermediate-acting insulin
Others

By Distribution Channel

Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Providers

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 LAMEA Human Insulin Market, by Indication
- 1.4.2 LAMEA Human Insulin Market, by Product Type
- 1.4.3 LAMEA Human Insulin Market, by Type of Insulin
- 1.4.4 LAMEA Human Insulin Market, by Distribution Channel
- 1.4.5 LAMEA Human Insulin Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Human Insulin Market by Indication

4.1 LAMEA Type 1 Diabetes Market by Country
4.2 LAMEA Type 2 Diabetes Market by Country
4.3 LAMEA Gestational Diabetes Market by Country

Chapter 5. LAMEA Human Insulin Market by Product Type

5.1 LAMEA Pens Market by Country
5.2 LAMEA Syringes Market by Country
5.3 LAMEA Others Market by Country

Chapter 6. LAMEA Human Insulin Market by Type of Insulin

6.1 LAMEA Rapid-acting insulin Market by Country
6.2 LAMEA Short-acting insulin Market by Country
6.3 LAMEA Intermediate-acting insulin Market by Country
6.4 LAMEA Others Market by Country

Chapter 7. LAMEA Human Insulin Market by Distribution Channel

7.1 LAMEA Hospital Pharmacies Market by Country
7.2 LAMEA Drug Stores & Retail Pharmacies Market by Country
7.3 LAMEA Online Providers Market by Country

Chapter 8. LAMEA Human Insulin Market by Country

8.1 Brazil Human Insulin Market
- 8.1.1 Brazil Human Insulin Market by Indication
- 8.1.2 Brazil Human Insulin Market by Product Type
- 8.1.3 Brazil Human Insulin Market by Type of Insulin
- 8.1.4 Brazil Human Insulin Market by Distribution Channel
8.2 Argentina Human Insulin Market
- 8.2.1 Argentina Human Insulin Market by Indication
- 8.2.2 Argentina Human Insulin Market by Product Type
- 8.2.3 Argentina Human Insulin Market by Type of Insulin
- 8.2.4 Argentina Human Insulin Market by Distribution Channel
8.3 UAE Human Insulin Market
- 8.3.1 UAE Human Insulin Market by Indication
- 8.3.2 UAE Human Insulin Market by Product Type
- 8.3.3 UAE Human Insulin Market by Type of Insulin
- 8.3.4 UAE Human Insulin Market by Distribution Channel
8.4 Saudi Arabia Human Insulin Market
- 8.4.1 Saudi Arabia Human Insulin Market by Indication
- 8.4.2 Saudi Arabia Human Insulin Market by Product Type
- 8.4.3 Saudi Arabia Human Insulin Market by Type of Insulin
- 8.4.4 Saudi Arabia Human Insulin Market by Distribution Channel
8.5 South Africa Human Insulin Market
- 8.5.1 South Africa Human Insulin Market by Indication
- 8.5.2 South Africa Human Insulin Market by Product Type
- 8.5.3 South Africa Human Insulin Market by Type of Insulin
- 8.5.4 South Africa Human Insulin Market by Distribution Channel
8.6 Nigeria Human Insulin Market
- 8.6.1 Nigeria Human Insulin Market by Indication
- 8.6.2 Nigeria Human Insulin Market by Product Type
- 8.6.3 Nigeria Human Insulin Market by Type of Insulin
- 8.6.4 Nigeria Human Insulin Market by Distribution Channel
8.7 Rest of LAMEA Human Insulin Market
- 8.7.1 Rest of LAMEA Human Insulin Market by Indication
- 8.7.2 Rest of LAMEA Human Insulin Market by Product Type
- 8.7.3 Rest of LAMEA Human Insulin Market by Type of Insulin
- 8.7.4 Rest of LAMEA Human Insulin Market by Distribution Channel

Chapter 9. Company Profiles

9.1 Biocon Limited
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Research & Development Expenses
9.2 Tonghua Dongbao Pharmaceutical Co., Ltd.
- 9.2.1 Company Overview
9.3 Lupin Limited
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 SWOT Analysis
9.4 MannKind Corporation
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
9.5 Sanofi S.A.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 SWOT Analysis
9.6 Novo Nordisk A/S
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental & Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 SWOT Analysis
9.7 Medtronic PLC
- 9.7.1 Company overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
9.8 Eli Lilly And Company
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 SWOT Analysis
9.9 Pfizer, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional & Segmental Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 SWOT Analysis

LIST OF TABLES

TABLE 1 LAMEA Human Insulin Market, 2020 - 2023, USD Million
TABLE 2 LAMEA Human Insulin Market, 2024 - 2031, USD Million
TABLE 3 LAMEA Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 4 LAMEA Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 5 LAMEA Type 1 Diabetes Market by Country, 2020 - 2023, USD Million
TABLE 6 LAMEA Type 1 Diabetes Market by Country, 2024 - 2031, USD Million
TABLE 7 LAMEA Type 2 Diabetes Market by Country, 2020 - 2023, USD Million
TABLE 8 LAMEA Type 2 Diabetes Market by Country, 2024 - 2031, USD Million
TABLE 9 LAMEA Gestational Diabetes Market by Country, 2020 - 2023, USD Million
TABLE 10 LAMEA Gestational Diabetes Market by Country, 2024 - 2031, USD Million
TABLE 11 LAMEA Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 12 LAMEA Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 13 LAMEA Pens Market by Country, 2020 - 2023, USD Million
TABLE 14 LAMEA Pens Market by Country, 2024 - 2031, USD Million
TABLE 15 LAMEA Syringes Market by Country, 2020 - 2023, USD Million
TABLE 16 LAMEA Syringes Market by Country, 2024 - 2031, USD Million
TABLE 17 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 18 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 19 LAMEA Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 20 LAMEA Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 21 LAMEA Rapid-acting insulin Market by Country, 2020 - 2023, USD Million
TABLE 22 LAMEA Rapid-acting insulin Market by Country, 2024 - 2031, USD Million
TABLE 23 LAMEA Short-acting insulin Market by Country, 2020 - 2023, USD Million
TABLE 24 LAMEA Short-acting insulin Market by Country, 2024 - 2031, USD Million
TABLE 25 LAMEA Intermediate-acting insulin Market by Country, 2020 - 2023, USD Million
TABLE 26 LAMEA Intermediate-acting insulin Market by Country, 2024 - 2031, USD Million
TABLE 27 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 28 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 29 LAMEA Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 30 LAMEA Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 31 LAMEA Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 32 LAMEA Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 33 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 34 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 35 LAMEA Online Providers Market by Country, 2020 - 2023, USD Million
TABLE 36 LAMEA Online Providers Market by Country, 2024 - 2031, USD Million
TABLE 37 LAMEA Human Insulin Market by Country, 2020 - 2023, USD Million
TABLE 38 LAMEA Human Insulin Market by Country, 2024 - 2031, USD Million
TABLE 39 Brazil Human Insulin Market, 2020 - 2023, USD Million
TABLE 40 Brazil Human Insulin Market, 2024 - 2031, USD Million
TABLE 41 Brazil Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 42 Brazil Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 43 Brazil Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 44 Brazil Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 45 Brazil Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 46 Brazil Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 47 Brazil Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 48 Brazil Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 49 Argentina Human Insulin Market, 2020 - 2023, USD Million
TABLE 50 Argentina Human Insulin Market, 2024 - 2031, USD Million
TABLE 51 Argentina Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 52 Argentina Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 53 Argentina Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 54 Argentina Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 55 Argentina Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 56 Argentina Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 57 Argentina Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 58 Argentina Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 59 UAE Human Insulin Market, 2020 - 2023, USD Million
TABLE 60 UAE Human Insulin Market, 2024 - 2031, USD Million
TABLE 61 UAE Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 62 UAE Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 63 UAE Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 64 UAE Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 65 UAE Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 66 UAE Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 67 UAE Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 68 UAE Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 69 Saudi Arabia Human Insulin Market, 2020 - 2023, USD Million
TABLE 70 Saudi Arabia Human Insulin Market, 2024 - 2031, USD Million
TABLE 71 Saudi Arabia Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 72 Saudi Arabia Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 73 Saudi Arabia Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 74 Saudi Arabia Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 75 Saudi Arabia Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 76 Saudi Arabia Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 77 Saudi Arabia Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 78 Saudi Arabia Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 79 South Africa Human Insulin Market, 2020 - 2023, USD Million
TABLE 80 South Africa Human Insulin Market, 2024 - 2031, USD Million
TABLE 81 South Africa Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 82 South Africa Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 83 South Africa Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 84 South Africa Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 85 South Africa Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 86 South Africa Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 87 South Africa Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 88 South Africa Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 89 Nigeria Human Insulin Market, 2020 - 2023, USD Million
TABLE 90 Nigeria Human Insulin Market, 2024 - 2031, USD Million
TABLE 91 Nigeria Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 92 Nigeria Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 93 Nigeria Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 94 Nigeria Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 95 Nigeria Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 96 Nigeria Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 97 Nigeria Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 98 Nigeria Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 99 Rest of LAMEA Human Insulin Market, 2020 - 2023, USD Million
TABLE 100 Rest of LAMEA Human Insulin Market, 2024 - 2031, USD Million
TABLE 101 Rest of LAMEA Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 102 Rest of LAMEA Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 103 Rest of LAMEA Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 104 Rest of LAMEA Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 105 Rest of LAMEA Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 106 Rest of LAMEA Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 107 Rest of LAMEA Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 108 Rest of LAMEA Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 109 Key Information - Biocon Limited
TABLE 110 Key Information - Tonghua Dongbao Pharmaceutical Co., Ltd.
TABLE 111 Key Information - Lupin Limited
TABLE 112 Key Information - MannKind Corporation
TABLE 113 Key Information - Sanofi S.A.
TABLE 114 Key Information - Novo Nordisk A/S
TABLE 115 Key Information - Medtronic PLC
TABLE 116 Key Information - Eli Lilly And Company
TABLE 117 Key Information - Pfizer, Inc.

LAMEA Human Insulin Market Size, Share & Trends Analysis Report By Indication, By Product Type (Pens, Syringes, and Others), By Type of Insulin, By Distribution Channel, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents